Asia-Pacific Oncology Injection Drug Industry 2017 Market Research Report

Published: Sep, 2017 | Pages: 119 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the Asia-Pacific Oncology Injection Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Oncology Injection Drug for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Oncology Injection Drug market competition by top manufacturers/players, with Oncology Injection Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Taj Oncology
    S.G. Biopharm
    AdvaCare
    Merrimack
    Celgene
    Allos Therapeutics
    Ferring Pharmaceuticals
    Genzyme
    Eli Lilly
    Praecis Pharmaceuticals
    Millennium Pharmaceuticals
    Debiopharm
    Alza
    CordenPharma
    Pharmascience

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
    Organs
    Central Nervous System
    Circulatory/Musculoskeletal System

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Oncology Injection Drug for each application, includin
    Lymphoma
    Myeloma
    Prostate Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Asia-Pacific Oncology Injection Drug Market Report 2017
1 Oncology Injection Drug Overview
    1.1 Product Overview and Scope of Oncology Injection Drug
    1.2 Classification of Oncology Injection Drug by Product Category
        1.2.1 Asia-Pacific Oncology Injection Drug Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Oncology Injection Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Organs
        1.2.4 Central Nervous System
        1.2.5 Circulatory/Musculoskeletal System
    1.3 Asia-Pacific Oncology Injection Drug Market by Application/End Users
        1.3.1 Asia-Pacific Oncology Injection Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Lymphoma
        1.3.3 Myeloma
        1.3.4 Prostate Cancer
    1.4 Asia-Pacific Oncology Injection Drug Market by Region
        1.4.1 Asia-Pacific Oncology Injection Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Oncology Injection Drug (2012-2022)
        1.5.1 Asia-Pacific Oncology Injection Drug Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Oncology Injection Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Oncology Injection Drug Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Oncology Injection Drug Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Oncology Injection Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Oncology Injection Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Oncology Injection Drug (Volume and Value) by Type
        2.2.1 Asia-Pacific Oncology Injection Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Oncology Injection Drug Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Oncology Injection Drug (Volume) by Application
    2.4 Asia-Pacific Oncology Injection Drug (Volume and Value) by Region
        2.4.1 Asia-Pacific Oncology Injection Drug Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Oncology Injection Drug Revenue and Market Share by Region (2012-2017)

3 China Oncology Injection Drug (Volume, Value and Sales Price)
    3.1 China Oncology Injection Drug Sales and Value (2012-2017)
        3.1.1 China Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        3.1.3 China Oncology Injection Drug Sales Price Trend (2012-2017)
    3.2 China Oncology Injection Drug Sales Volume and Market Share by Type
    3.3 China Oncology Injection Drug Sales Volume and Market Share by Application

4 Japan Oncology Injection Drug (Volume, Value and Sales Price)
    4.1 Japan Oncology Injection Drug Sales and Value (2012-2017)
        4.1.1 Japan Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Oncology Injection Drug Sales Price Trend (2012-2017)
    4.2 Japan Oncology Injection Drug Sales Volume and Market Share by Type
    4.3 Japan Oncology Injection Drug Sales Volume and Market Share by Application

5 South Korea Oncology Injection Drug (Volume, Value and Sales Price)
    5.1 South Korea Oncology Injection Drug Sales and Value (2012-2017)
        5.1.1 South Korea Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Oncology Injection Drug Sales Price Trend (2012-2017)
    5.2 South Korea Oncology Injection Drug Sales Volume and Market Share by Type
    5.3 South Korea Oncology Injection Drug Sales Volume and Market Share by Application

6 Taiwan Oncology Injection Drug (Volume, Value and Sales Price)
    6.1 Taiwan Oncology Injection Drug Sales and Value (2012-2017)
        6.1.1 Taiwan Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Oncology Injection Drug Sales Price Trend (2012-2017)
    6.2 Taiwan Oncology Injection Drug Sales Volume and Market Share by Type
    6.3 Taiwan Oncology Injection Drug Sales Volume and Market Share by Application

7 India Oncology Injection Drug (Volume, Value and Sales Price)
    7.1 India Oncology Injection Drug Sales and Value (2012-2017)
        7.1.1 India Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        7.1.3 India Oncology Injection Drug Sales Price Trend (2012-2017)
    7.2 India Oncology Injection Drug Sales Volume and Market Share by Type
    7.3 India Oncology Injection Drug Sales Volume and Market Share by Application

8 Southeast Asia Oncology Injection Drug (Volume, Value and Sales Price)
    8.1 Southeast Asia Oncology Injection Drug Sales and Value (2012-2017)
        8.1.1 Southeast Asia Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Oncology Injection Drug Sales Price Trend (2012-2017)
    8.2 Southeast Asia Oncology Injection Drug Sales Volume and Market Share by Type
    8.3 Southeast Asia Oncology Injection Drug Sales Volume and Market Share by Application

9 Australia Oncology Injection Drug (Volume, Value and Sales Price)
    9.1 Australia Oncology Injection Drug Sales and Value (2012-2017)
        9.1.1 Australia Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Oncology Injection Drug Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Oncology Injection Drug Sales Price Trend (2012-2017)
    9.2 Australia Oncology Injection Drug Sales Volume and Market Share by Type
    9.3 Australia Oncology Injection Drug Sales Volume and Market Share by Application

10 Asia-Pacific Oncology Injection Drug Players/Suppliers Profiles and Sales Data
    10.1 Taj Oncology
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Oncology Injection Drug Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 S.G. Biopharm
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Oncology Injection Drug Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 AdvaCare
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Oncology Injection Drug Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Merrimack
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Oncology Injection Drug Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Celgene
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Oncology Injection Drug Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Allos Therapeutics
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Oncology Injection Drug Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Ferring Pharmaceuticals
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Oncology Injection Drug Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Genzyme
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Oncology Injection Drug Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Eli Lilly
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Oncology Injection Drug Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Praecis Pharmaceuticals
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Oncology Injection Drug Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Millennium Pharmaceuticals
    10.12 Debiopharm
    10.13 Alza
    10.14 CordenPharma
    10.15 Pharmascience

11 Oncology Injection Drug Manufacturing Cost Analysis
    11.1 Oncology Injection Drug Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Oncology Injection Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Oncology Injection Drug Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Oncology Injection Drug Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Oncology Injection Drug Market Forecast (2017-2022)
    15.1 Asia-Pacific Oncology Injection Drug Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Oncology Injection Drug Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Oncology Injection Drug Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Oncology Injection Drug Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Oncology Injection Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Oncology Injection Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Oncology Injection Drug Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Oncology Injection Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Oncology Injection Drug Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Oncology Injection Drug Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Oncology Injection Drug Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Oncology Injection Drug Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Oncology Injection Drug Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer

List of Tables and Figures


    Figure Product Picture of Oncology Injection Drug
    Figure Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Volume Market Share by Type (Product Category) in 2016
    Figure Organs Product Picture
    Figure Central Nervous System Product Picture
    Figure Circulatory/Musculoskeletal System Product Picture
    Figure Asia-Pacific Oncology Injection Drug Sales (K Pcs) by Application (2012-2022)
    Figure Asia-Pacific Sales Market Share of Oncology Injection Drug by Application in 2016
    Figure Lymphoma Examples
    Table Key Downstream Customer in Lymphoma
    Figure Myeloma Examples
    Table Key Downstream Customer in Myeloma
    Figure Prostate Cancer Examples
    Table Key Downstream Customer in Prostate Cancer
    Figure Asia-Pacific Oncology Injection Drug Market Size (Million USD) by Region (2012-2022)
    Figure China Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure South Korea Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Taiwan Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Australia Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
    Figure Asia-Pacific Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Oncology Injection Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Oncology Injection Drug Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Oncology Injection Drug Sales Share by Players/Suppliers
    Figure Asia-Pacific Oncology Injection Drug Market Major Players Product Revenue (Million USD) 2012-2017
    Table Asia-Pacific Oncology Injection Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Oncology Injection Drug Revenue Share by Players
    Figure 2017 Asia-Pacific Oncology Injection Drug Revenue Share by Players
    Table Asia-Pacific Oncology Injection Drug Sales and Market Share by Type (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales Share by Type (2012-2017)
    Figure Sales Market Share of Oncology Injection Drug by Type (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Sales Growth Rate by Type (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Oncology Injection Drug by Type (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Revenue Growth Rate by Type (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales Share by Region (2012-2017)
    Figure Sales Market Share of Oncology Injection Drug by Region (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Sales Market Share by Region in 2016
    Table Asia-Pacific Oncology Injection Drug Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Oncology Injection Drug by Region (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Revenue Market Share by Region in 2016
    Table Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
    Table Asia-Pacific Oncology Injection Drug Sales Share (%) by Application (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Sales Market Share by Application (2012-2017)
    Figure Asia-Pacific Oncology Injection Drug Sales Market Share by Application (2012-2017)
    Figure China Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure China Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table China Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table China Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure China Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table China Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table China Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure China Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure Japan Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Japan Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table Japan Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table Japan Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure Japan Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table Japan Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table Japan Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure Japan Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure South Korea Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure South Korea Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure South Korea Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table South Korea Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table South Korea Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure South Korea Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table South Korea Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table South Korea Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure South Korea Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure Taiwan Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Taiwan Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Taiwan Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table Taiwan Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table Taiwan Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure Taiwan Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table Taiwan Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table Taiwan Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure Taiwan Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure India Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure India Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table India Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table India Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure India Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table India Oncology Injection Drug Sales Volume (K Pcs) by Application (2012-2017)
    Table India Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure India Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Southeast Asia Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table Southeast Asia Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table Southeast Asia Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table Southeast Asia Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table Southeast Asia Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Figure Australia Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Australia Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Australia Oncology Injection Drug Sales Price (USD/Pcs) Trend (2012-2017)
    Table Australia Oncology Injection Drug Sales Volume (K Pcs) by Type (2012-2017)
    Table Australia Oncology Injection Drug Sales Volume Market Share by Type (2012-2017)
    Figure Australia Oncology Injection Drug Sales Volume Market Share by Type in 2016
    Table Australia Oncology Injection Drug Sales Volume (K Pcs) by Applications (2012-2017)
    Table Australia Oncology Injection Drug Sales Volume Market Share by Application (2012-2017)
    Figure Australia Oncology Injection Drug Sales Volume Market Share by Application in 2016
    Table Taj Oncology Oncology Injection Drug Basic Information List
    Table Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Taj Oncology Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Taj Oncology Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Taj Oncology Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table S.G. Biopharm Oncology Injection Drug Basic Information List
    Table S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure S.G. Biopharm Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure S.G. Biopharm Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure S.G. Biopharm Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table AdvaCare Oncology Injection Drug Basic Information List
    Table AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure AdvaCare Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure AdvaCare Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure AdvaCare Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Merrimack Oncology Injection Drug Basic Information List
    Table Merrimack Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Merrimack Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Merrimack Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Merrimack Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Celgene Oncology Injection Drug Basic Information List
    Table Celgene Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Celgene Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Celgene Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Celgene Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Allos Therapeutics Oncology Injection Drug Basic Information List
    Table Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Allos Therapeutics Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Allos Therapeutics Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Allos Therapeutics Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Ferring Pharmaceuticals Oncology Injection Drug Basic Information List
    Table Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Ferring Pharmaceuticals Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Ferring Pharmaceuticals Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Genzyme Oncology Injection Drug Basic Information List
    Table Genzyme Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Genzyme Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Genzyme Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Genzyme Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Eli Lilly Oncology Injection Drug Basic Information List
    Table Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Eli Lilly Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Eli Lilly Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Eli Lilly Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Praecis Pharmaceuticals Oncology Injection Drug Basic Information List
    Table Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Praecis Pharmaceuticals Oncology Injection Drug Sales Market Share in Asia-Pacific (2012-2017)
    Figure Praecis Pharmaceuticals Oncology Injection Drug Revenue Market Share in Asia-Pacific (2012-2017)
    Table Millennium Pharmaceuticals Oncology Injection Drug Basic Information List
    Table Debiopharm Oncology Injection Drug Basic Information List
    Table Alza Oncology Injection Drug Basic Information List
    Table CordenPharma Oncology Injection Drug Basic Information List
    Table Pharmascience Oncology Injection Drug Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price (USD/Pcs) Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Oncology Injection Drug
    Figure Manufacturing Process Analysis of Oncology Injection Drug
    Figure Oncology Injection Drug Industrial Chain Analysis
    Table Raw Materials Sources of Oncology Injection Drug Major Manufacturers in 2016
    Table Major Buyers of Oncology Injection Drug
    Table Distributors/Traders List
    Figure Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
    Table Asia-Pacific Oncology Injection Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Volume Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Volume Market Share Forecast by Region in 2022
    Table Asia-Pacific Oncology Injection Drug Revenue (Million USD) Forecast by Region (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Revenue Market Share Forecast by Region (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Revenue Market Share Forecast by Region in 2022
    Figure China Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure China Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Japan Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure South Korea Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure South Korea Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Taiwan Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure India Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure India Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Australia Oncology Injection Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure Australia Oncology Injection Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Table Asia-Pacific Oncology Injection Drug Sales (K Pcs) Forecast by Type (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Oncology Injection Drug Revenue (Million USD) Forecast by Type (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Revenue Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Oncology Injection Drug Price (USD/Pcs) Forecast by Type (2017-2022)
    Table Asia-Pacific Oncology Injection Drug Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Asia-Pacific Oncology Injection Drug Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources